Cochrane Abstracts
Sublingual immunotherapy for treating allergic conjunctivitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sublingual Immunotherapy for Treating Allergic Conjunctivitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440067/all/Sublingual_immunotherapy_for_treating_allergic_conjunctivitis.
Sublingual immunotherapy for treating allergic conjunctivitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440067/all/Sublingual_immunotherapy_for_treating_allergic_conjunctivitis. Accessed February 3, 2025.
Sublingual immunotherapy for treating allergic conjunctivitis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440067/all/Sublingual_immunotherapy_for_treating_allergic_conjunctivitis
Sublingual Immunotherapy for Treating Allergic Conjunctivitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440067/all/Sublingual_immunotherapy_for_treating_allergic_conjunctivitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sublingual immunotherapy for treating allergic conjunctivitis
ID - 440067
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440067/all/Sublingual_immunotherapy_for_treating_allergic_conjunctivitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
